Research location
Istanbul
Fatih, Turkey (Türkiye)
Advertisement
Research activity in Istanbul
Fatih, Turkey (Türkiye)CureCurrent currently publishes aggregate city-level research activity for this location: 35 trials and 38 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Istanbul
34 linked trials · page 1 of 1Investigation of the Effect of Inspiratory Muscle Training and Dual-Task Inspiratory Muscle Training on Cognitive Functions in Heart FailureNCT07581587 · 2026-07-27 · 1 site observation
RECRUITING
Dietary Nitrate and the Oral Microbiome in Children With Primary HypertensionNCT07236125 · 2026-04-15 · 1 site observation
RECRUITING
Phase IIIb Study of Ribociclib + ET in Early Breast CancerNCT05827081 · 2024-02-28 · 1 site observation
RECRUITING
Effectiveness of a Home-Based Exercise Program Supported by Self-Management Education in People With Parkinson DiseaseNCT07817862 · 2026-09-10 · 1 site observation
NOT_YET_RECRUITING
Effectiveness of a Tele-Rehabilitation-Based Exercise and Self-Lymphatic Drainage Program Supported by Self-Management for Breast Cancer-Related LymphedemaNCT07794904 · 2026-09-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Virtual Reality in Patients With Pulmonary Hypertension: A Randomized Controlled TrialNCT07558460 · 2026-01-31 · 1 site observation
ENROLLING_BY_INVITATION
Pain Neuroscience Education and Vagus Nerve Stimulation on Recovery in Individuals With Rheumatoid ArthritisNCT07274124 · 2026-01-01 · 1 site observation
NOT_YET_RECRUITING
Micro Ribonucleic Acid (miRNA) Expression and Inflammatory Factors in Patients With Parkinson's and Periodontal DiseaseNCT07099378 · 2025-08-01 · 1 site observation
NOT_YET_RECRUITING
Nicardipine vs. LabetalolNCT07277283 · 2025-02-01 · 1 site observation
COMPLETED
The Effects of the Otago Exercise ProgramNCT06172790 · 2024-02-01 · 1 site observation
UNKNOWN
HFNC vs. NIV in Acute COPD ExacerbationsNCT06495086 · 2023-09-01 · 1 site observation
COMPLETED
Drug Compliance and Affecting Factors in Juvenile Idiopathic ArthritisNCT06000566 · 2022-12-01 · 1 site observation
COMPLETED
Longitudinal Changes in Left and Right Ventricular Global Strain After Chemotherapy in Cardiac Light Chain AmyloidosisNCT05452850 · 2022-08-11 · 1 site observation
UNKNOWN
Study of JDQ443 in Comparison With Docetaxel in Participants With Locally Advanced or Metastatic KRAS G12C Mutant Non-small Cell Lung CancerNCT05132075 · 2022-06-15 · 1 site observation
ACTIVE_NOT_RECRUITING
Kynurenine Pathway in Parkinson's DiseaseNCT07272564 · 2022-05-15 · 1 site observation
COMPLETED
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)NCT05156281 · 2021-12-13 · 2 site observations
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple SclerosisNCT04926818 · 2021-10-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With IntentNCT04722666 · 2021-07-20 · 1 site observation
TERMINATED
Real-World Data on Clinical Characteristics, Demographics, and Outcomes of Patients With Metastatic Breast Cancer in TurkeyNCT04770129 · 2021-03-22 · 1 site observation
COMPLETED
Evaluation of the Effect and Side Effect Profile of Covid-19 Vaccine in Cancer PatientsNCT04771559 · 2021-03-01 · 2 site observations
COMPLETED
Effects of Bedtime Snack Composition on Overnight Glucose in Children and Adolescents With Type 1 DiabetesNCT07778147 · 2020-11-19 · 1 site observation
COMPLETED
An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Fumarate-based RMS Approved Therapies or Fingolimod to OfatumumabNCT04353492 · 2020-07-14 · 1 site observation
COMPLETED
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN LossNCT04251533 · 2020-06-08 · 1 site observation
TERMINATED
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MSNCT03650114 · 2018-12-28 · 1 site observation
ACTIVE_NOT_RECRUITING
The Short and Long-term Effects of Low Advanced Glycation End Product* DietNCT06005519 · 2018-12-01 · 1 site observation
COMPLETED
The Effect of Dual Tasking on Physical and Cognitive Functions in Patients With Parkinson DiseaseNCT03902990 · 2018-10-01 · 1 site observation
COMPLETED
Postoperative BMI Changes and Functional Outcomes in Knee and Hip ArthroplastyNCT06440863 · 2018-01-01 · 1 site observation
COMPLETED
The Prelieve Trial - Pilot Study to Assess Safety and Efficacy of a Novel Atrial Flow Regulator (AFR) in Heart Failure PatientsNCT03030274 · 2017-10-11 · 1 site observation
COMPLETED
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued TreatmentNCT02962414 · 2017-08-23 · 1 site observation
ACTIVE_NOT_RECRUITING
CINC424A2X01B Rollover ProtocolNCT02386800 · 2015-03-05 · 1 site observation
ACTIVE_NOT_RECRUITING
Axillary Block Properties in Diabetic PatientsNCT02685475 · 2015-02-01 · 1 site observation
COMPLETED
Effects of Oral Sildenafil on Mortality in Adults With PAHNCT02060487 · 2014-09-22 · 2 site observations
TERMINATED
Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple SclerosisNCT01892722 · 2013-07-26 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of S-amlodipine 2,5 mg and 5 mg in Hypertension PatientsNCT03038451 · 2013-03-20 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.